The financial pressures faced by HIV clinics in the NHS was a major theme of the recent British HIV Association conference. Doctors discussed how they can keep costs down without compromising the quality of care. One of the most important ways they can do so is to switch some patients from branded, expensive drugs to […]
Atripla, a recommended first-line regimen in antiretroviral treatment, is widely used, highly effective, convenient and generally considered safe and well tolerated. But a significant minority of people taking efavirenz – an ingredient in the all-in-one Atripla pill – experience neuropsychiatric symptoms that may include insomnia, vivid dreams or nightmares, and depression or anxiety. A new study […]
Until now, it was advised that efavirenz, a widely-used anti-retroviral drug for the treatment of HIV, be avoided during pregnancy. New draft UK guidelines on the treatment of HIV in pregnancy no longer recommend that efavirenz (Sustiva, also part of the combination pill Atripla) should be avoided by pregnant women and women hoping to become pregnant. This means that women […]